Securities and Exchange Commission

Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements

Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.

Compare To Other Companies

Annual (shares)

Value	Reported On	Form	FY	FP	Start Date	End Date	Fiscal Period
0	2013-03-04	10-K	2012	FY	2010-01-01	2010-12-31	CY2010
366,000	2014-03-03	10-K	2013	FY	2011-01-01	2011-12-31	CY2011
0	2015-03-02	10-K	2014	FY	2012-01-01	2012-12-31	CY2012
0	2015-03-02	10-K	2014	FY	2013-01-01	2013-12-31	CY2013
0	2016-02-29	10-K	2015	FY	2014-01-01	2014-12-31	CY2014
0	2017-03-31	10-K	2016	FY	2015-01-01	2015-12-31	CY2015
0	2018-06-07	10-K	2017	FY	2016-01-01	2016-12-31	CY2016
0	2018-06-07	10-K	2017	FY	2017-01-01	2017-12-31	CY2017
1,254,000	2023-06-30	10-K	2021	FY	2020-01-01	2020-12-31	CY2020
1,031,000	2023-06-30	10-K	2021	FY	2021-01-01	2021-12-31	CY2021

Quarterly (shares)

Value	Reported On	Form	FY	FP	Start Date	End Date	Fiscal Period
240,000	2012-08-09	10-Q/A	2012	Q2	2011-04-01	2011-06-30	CY2011Q2
0	2012-11-06	10-Q	2012	Q3	2011-07-01	2011-09-30	CY2011Q3
0	2012-08-09	10-Q/A	2012	Q2	2012-04-01	2012-06-30	CY2012Q2
0	2012-11-06	10-Q	2012	Q3	2012-07-01	2012-09-30	CY2012Q3
0	2014-05-05	10-Q	2014	Q1	2013-01-01	2013-03-31	CY2013Q1
0	2015-05-04	10-Q	2015	Q1	2014-01-01	2014-03-31	CY2014Q1
33,000	2016-05-02	10-Q	2016	Q1	2015-01-01	2015-03-31	CY2015Q1
0	2017-05-12	10-Q	2017	Q1	2016-01-01	2016-03-31	CY2016Q1
0	2017-05-12	10-Q	2017	Q1	2017-01-01	2017-03-31	CY2017Q1
115,000	2021-08-16	10-Q	2021	Q2	2020-04-01	2020-06-30	CY2020Q2
0	2021-08-16	10-Q	2021	Q2	2021-04-01	2021-06-30	CY2021Q2

All Reported Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements (shares)

Value	Reported On	Form	FY	FP	Start Date	End Date	Fiscal Period
0	2013-03-04	10-K	2012	FY	2010-01-01	2010-12-31	CY2010
173,000	2012-08-09	10-Q/A	2012	Q2	2011-01-01	2011-06-30
240,000	2012-08-09	10-Q/A	2012	Q2	2011-04-01	2011-06-30	CY2011Q2
142,000	2012-11-06	10-Q	2012	Q3	2011-01-01	2011-09-30
0	2012-11-06	10-Q	2012	Q3	2011-07-01	2011-09-30	CY2011Q3
366,000	2013-03-04	10-K	2012	FY	2011-01-01	2011-12-31
366,000	2014-03-03	10-K	2013	FY	2011-01-01	2011-12-31	CY2011
0	2012-08-09	10-Q/A	2012	Q2	2012-01-01	2012-06-30
0	2012-08-09	10-Q/A	2012	Q2	2012-04-01	2012-06-30	CY2012Q2
0	2012-11-06	10-Q	2012	Q3	2012-01-01	2012-09-30
0	2012-11-06	10-Q	2012	Q3	2012-07-01	2012-09-30	CY2012Q3
0	2013-03-04	10-K	2012	FY	2012-01-01	2012-12-31
0	2014-03-03	10-K	2013	FY	2012-01-01	2012-12-31
0	2015-03-02	10-K	2014	FY	2012-01-01	2012-12-31	CY2012
0	2014-05-05	10-Q	2014	Q1	2013-01-01	2013-03-31	CY2013Q1
0	2014-03-03	10-K	2013	FY	2013-01-01	2013-12-31
0	2015-03-02	10-K	2014	FY	2013-01-01	2013-12-31	CY2013
0	2014-05-05	10-Q	2014	Q1	2014-01-01	2014-03-31
0	2015-05-04	10-Q	2015	Q1	2014-01-01	2014-03-31	CY2014Q1
0	2015-03-02	10-K	2014	FY	2014-01-01	2014-12-31
0	2016-02-29	10-K	2015	FY	2014-01-01	2014-12-31	CY2014
167,000	2015-05-04	10-Q	2015	Q1	2015-01-01	2015-03-31
33,000	2016-05-02	10-Q	2016	Q1	2015-01-01	2015-03-31	CY2015Q1
0	2016-02-29	10-K	2015	FY	2015-01-01	2015-12-31
0	2017-03-31	10-K	2016	FY	2015-01-01	2015-12-31	CY2015
0	2016-05-02	10-Q	2016	Q1	2016-01-01	2016-03-31
0	2017-05-12	10-Q	2017	Q1	2016-01-01	2016-03-31	CY2016Q1
0	2017-03-31	10-K	2016	FY	2016-01-01	2016-12-31
0	2018-06-07	10-K	2017	FY	2016-01-01	2016-12-31	CY2016
0	2017-05-12	10-Q	2017	Q1	2017-01-01	2017-03-31	CY2017Q1
0	2018-06-07	10-K	2017	FY	2017-01-01	2017-12-31	CY2017
115,000	2021-08-16	10-Q	2021	Q2	2020-04-01	2020-06-30	CY2020Q2
1,254,000	2023-06-30	10-K	2021	FY	2020-01-01	2020-12-31	CY2020
0	2021-08-16	10-Q	2021	Q2	2021-04-01	2021-06-30	CY2021Q2
1,031,000	2023-06-30	10-K	2021	FY	2021-01-01	2021-12-31	CY2021